Randomized phase II open-label study of mFOLFOX6 in combination with linifanib or bevacizumab for metastatic colorectal cancer. This is an ASCO Meeting Abstract from the 2012 ASCO Annual Meeting I.
BOULDER, Colo. & CAMBRIDGE, UK--(BUSINESS WIRE)--ArcherDX, Inc., a leader in NGS fusion detection, in partnership with Horizon Discovery Group plc (LSE:HZD) (Horizon), the international life science ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback